Detection of Prostate Cancer Antigen 3 and Prostate Cancer Susceptibility Candidate in Non-DRE Urine Improves Diagnosis of Prostate Cancer in Chinese Population

Although prostate biopsy is the gold standard for the diagnosis of prostate cancer, it also leads to high incidence of negative biopsies and the diagnosis of clinically low-risk prostate cancer and the subsequent overtreatment. It remains an unmet need to discover new biomarkers in order to defer th...

Full description

Bibliographic Details
Main Authors: Lie-Fu Ye, Sha He, Xiaopei Wu, Shengying Jiang, Ruo-Chen Zhang, Ze-Song Yang, Fa-Wen Chen, Dan-Ling Pan, Dong Li, Gang Li
Format: Article
Language:English
Published: Hindawi Limited 2020-01-01
Series:Prostate Cancer
Online Access:http://dx.doi.org/10.1155/2020/3964615

Similar Items